Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The non-insulin dependent type-2 diabetes is a metabolic disorder and over a period of time those affected need to be on medication to be able to maintain sugar levels.
Trials on new medicines are frequently conducted to come up with better drugs to deal with complications arising out of the disease as due to advanced screening methods the prevalence of type 2 diabetes is increasing alarmingly.
Boehringer Ingelheim and Eli Lilly and company, that work together in the field of diabetes care, recently announced new data on linagliptin, a drug that was launched in India last year under the brand name Trajenta, showing reduction in blood glucose levels in type-2 diabetic Asians aged above 65 years.
http://www.hindustantimes.com/enter...tive-for-liver-patients/article1-1153734.aspx
Trials on new medicines are frequently conducted to come up with better drugs to deal with complications arising out of the disease as due to advanced screening methods the prevalence of type 2 diabetes is increasing alarmingly.
Boehringer Ingelheim and Eli Lilly and company, that work together in the field of diabetes care, recently announced new data on linagliptin, a drug that was launched in India last year under the brand name Trajenta, showing reduction in blood glucose levels in type-2 diabetic Asians aged above 65 years.
http://www.hindustantimes.com/enter...tive-for-liver-patients/article1-1153734.aspx